During the past decade, Ustav pro peci o matku a dite conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ustav pro peci o matku a dite" #1 collaborator was "Cytel Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "PhinC Development" with 1 trials as a collaborator and "Scope International AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ustav pro peci o matku a dite" are "Congenital Heart Disease" (1 trials), "Immunity" (1 trials), "Preterm Labor" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Ustav pro peci o matku a dite" in a lesser frequency.

Most popular intervention types in "Ustav pro peci o matku a dite" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atosiban" (1 trials), "Infant formula with added synbiotics" (1 trials), "Motavizumab" (1 trials), "OBE022" (1 trials) and "Palivizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ustav pro peci o matku a dite" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ustav pro peci o matku a dite". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ustav pro peci o matku a dite, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ustav pro peci o matku a dite, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".